Gastro Intestinal, Endocrine, Nutrition & Blood Generic Medicines
A Contract Award Notice
by THE COMMON SERVICES AGENCY (MORE COMMONLY KNOWN AS NHS NATIONAL SERVICES SCOTLAND) ("NSS")
- Source
- Find a Tender
- Type
- Framework (Goods)
- Duration
- not specified
- Value
- £102K-£18M
- Sector
- HEALTH
- Published
- 23 Aug 2021
- Delivery
- not specified
- Deadline
- n/a
Related Terms
Location
All entities constituted pursuant to the National Health Services (Scotland) Act 1978, and any Integrated Joint Boards established pursuant to New Public Bodies (Joint Working) Scotland Act 2014
Geochart for 1 buyers and 67 suppliers
1 buyer
- NHS National Services Scotland NSS Edinburgh
46 suppliers
- Kent Pharmaceuticals Ashford
- Norgine Pharmaceuticals Uxbridge
- Tillotts Pharmaltd Lincoln
- Galen Craigavon
- Martindale Pharma Romford
- Kyowa Kirin Galashiels
- Thornton & Ross Huddersfield
- Accord Devon
- DR Falk Pharma Bucks
- Mylan Hatfield
- Zentiva Pharma London
- Univar Solutions Bradford
- Tillomed Laboratories Luton
- Orphalan London
- Hameln Pharma Gloucester
- Consilient Health Richmond
- Panpharma Liverpool
- Pfizer Tadworth
- Wockhardt Wrexham
- Baxter Healthcare Berkshire
- Bowmed Ibisqus Wrexham
- Colonis Pharma Burnopfield
- Brown & Burk West London
- Crescent Pharma Basingstoke
- CST Pharma Walsall
- Ennogen Healthcare Dartford
- Ferring Pharmaceuticals West Drayton
- Focus Pharmaceuticals Burton upon Trent
- Glaxosmithkline Uxbridge
- Glenmark Pharmaceuticals Europe Watford
- Intrapharm Laboratories Maidenhead
- Medreich Middlesex
- Mercury Pharma Group Croydon
- Morningside Pharmaceuticals Leicestershire
- Ranbaxy London
- Reckitt Benckiser Slough
- Rosemont Pharmaceuticals Leeds
- Sandoz Camberley
- Seacross Pharmaceuticals Bedford
- Selective Supplies Haywards Heath
- Synchrony Pharma Stevenage
- Teva Castleford
- Typharm Norwich
- Eurocept Ankeveen
- Allergan Marlow
- Takeda Bucks
Description
This Framework Agreement is for the supply of a range of Gastro Intestinal, Endocrine, Nutrition & Blood Generic Medicines to NHS Scotland. The Goods have been separated into eleven (11) categories, each of which is identified as a “Lot”. Full details of each Lot is contained in section II.2 of this notice.
Lot Division
| 1 | Desferrioxamine Injections Supply of Desferrioxamine Injections to NHS Scotland in a range of presentations. The Authority has awarded all presentations within this lot to a single supplier. |
| 2 | Dexamethasone Injections The Supply of Dexamethasone Injections The Authority has awarded each product line as an unranked multi-supplier framework agreement to six (6) Framework Participants |
| 3 | Macrogol Oral Powder & Solutions The Supply of Macrogol Oral Powder & Solutions The Authority has awarded each product line as an unranked multi-supplier framework agreement to three (3) Framework Participants |
| 4 | Mesalazine The Supply of Mesalazine to NHS Scotland in a range of presentations. The Authority has awarded each product line as an unranked multi-supplier framework agreement to six (6) Framework Participants |
| 5 | Magnesium Sulfate The supply of Magnesium sulfate to NHS Scotland in a range of presentations. The Authority has awarded each product line as an unranked multi-supplier framework agreement to two (2) Framework Participants |
| 6 | Calcium Carbonate Tablets The Supply of Calcium Carbonate Tablets to NHS Scotland in a range of presentations. The Authority has awarded each product line as an unranked multi-supplier framework agreement to three (3) Framework Participants. |
| 7 | Budesonide The supply of Budesonide to NHS Scotland in a range of presentations. The Authority has awarded each product line as an unranked multi-supplier framework agreement to two (2) Framework Participants |
| 9 | Pancreatin The supply of Pancreatin to NHS Scotland in a range of presentations. The Authority has awarded each product line as an unranked multi-supplier framework agreement to two (2) Framework Participants |
| 10 | All Other Presentations Supply of all other products/presentations within this tender to NHS Scotland. Each product line was treated as an individual Lot, and the Authority has awarded each lot to a single framework participant. |
| 11 | Trientine Supply of Trientine within this tender to NHS Scotland. Each product line was treated as an individual Lot, and has been awarded to a single Framework Participant. |
Award Detail
| 1 | Kent Pharmaceuticals (Ashford)
|
| 2 | Norgine Pharmaceuticals (Uxbridge)
|
| 3 | Tillotts Pharmaltd (Lincoln)
|
| 4 | Galen (Craigavon)
|
| 5 | Martindale Pharma (Romford)
|
| 6 | Kent Pharmaceuticals (Ashford)
|
| 7 | Kyowa Kirin (Galashiels)
|
| 8 | Thornton & Ross (Huddersfield)
|
| 9 | Accord (Devon)
|
| 10 | Tillotts Pharmaltd (Lincoln)
|
| 11 | DR Falk Pharma (Bucks)
|
| 12 | Mylan (Hatfield)
|
| 13 | Zentiva Pharma (London)
|
| 14 | Univar Solutions (Bradford)
|
| 15 | Tillomed Laboratories (Luton)
|
| 16 | Orphalan (London)
|
| 17 | Kent Pharmaceuticals (Ashford)
|
| 18 | Hameln Pharma (Gloucester)
|
| 19 | Consilient Health (Richmond)
|
| 20 | Panpharma (Liverpool)
|
| 21 | Pfizer (Tadworth)
|
| 22 | Wockhardt (Wrexham)
|
| 23 | Accord (Devon)
|
| 24 | Baxter Healthcare (Berkshire)
|
| 25 | Bowmed Ibisqus (Wrexham)
|
| 26 | Consilient Health (Richmond)
|
| 27 | Colonis Pharma (Burnopfield)
|
| 28 | Brown & Burk (West London)
|
| 29 | Crescent Pharma (Basingstoke)
|
| 30 | CST Pharma (Walsall)
|
| 31 | DR Falk Pharma (Bucks)
|
| 32 | Ennogen Healthcare (Dartford)
|
| 33 | Ferring Pharmaceuticals (West Drayton)
|
| 34 | Focus Pharmaceuticals (Burton upon Trent)
|
| 35 | Galen (Craigavon)
|
| 36 | Glaxosmithkline (Uxbridge)
|
| 37 | Glenmark Pharmaceuticals Europe (Watford)
|
| 38 | Hameln Pharma (Gloucester)
|
| 39 | Intrapharm Laboratories (Maidenhead)
|
| 40 | Kent Pharmaceuticals (Ashford)
|
| 41 | Kyowa Kirin (Galashiels)
|
| 42 | Martindale Pharma (Romford)
|
| 43 | Medreich (Middlesex)
|
| 44 | Mercury Pharma Group (Croydon)
|
| 45 | Morningside Pharmaceuticals (Leicestershire)
|
| 46 | Mylan (Hatfield)
|
| 47 | Pfizer (Tadworth)
|
| 48 | Ranbaxy (London)
|
| 49 | Reckitt Benckiser (Slough)
|
| 50 | Rosemont Pharmaceuticals (Leeds)
|
| 51 | Sandoz (Camberley)
|
| 52 | Seacross Pharmaceuticals (Bedford)
|
| 53 | Selective Supplies (Haywards Heath)
|
| 54 | Synchrony Pharma (Stevenage)
|
| 55 | Teva (Castleford)
|
| 56 | Thornton & Ross (Huddersfield)
|
| 57 | Tillomed Laboratories (Luton)
|
| 58 | Typharm (Norwich)
|
| 59 | Wockhardt (Wrexham)
|
| 60 | Zentiva Pharma (London)
|
| 61 | Eurocept (Ankeveen)
|
| 62 | DR Falk Pharma (Bucks)
|
| 63 | Ferring Pharmaceuticals (West Drayton)
|
| 64 | Tillotts Pharmaltd (Lincoln)
|
| 65 | Morningside Pharmaceuticals (Leicestershire)
|
| 66 | Allergan (Marlow)
|
| 67 | Takeda (Bucks)
|
Award Criteria
| Logistics | 5 |
| price | 95 |
CPV Codes
- 33600000 - Pharmaceutical products
Indicators
Other Information
** PREVIEW NOTICE, please check Find a Tender for full details. ** The estimated value referred to in Sections II.I.5 and within each Lot covers the twenty-four (24) months contract duration and the full twenty-four (24) months extension options. The Authority has not awarded any products within Lot 8 Vitamins with Minerals and Trace elements as no bids received. (SC Ref:662986)
Reference
- ocds-h6vhtk-02a379
- FTS 020715-2021